We are monitoring the impact of COVID-19 on Cardiovascular Therapeutic Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 1350
Share on
Share on

Global Cardiovascular Therapeutic Drugs Market Analysis – By Disease Type, Drug Class and Region – Industry Size, Share, Trends, Growth Opportunities Assessment and Forecast | 2019 – 2024

Pulished: August, 2019
ID: 1350
Pages: 175

Cardiovascular Therapeutic Drugs Market Size & Growth (2019 - 2024)

The size of the Global Cardiovascular Therapeutic Drugs Market is currently worth USD 135.4 billion in 2019 and is projected to reach USD 151.1 billion by 2024 growing at a CAGR of 2.22% during the forecast period 2019 - 2024.

The past few decades have witnessed significant success in the development of highly effective drug therapies for common cardiovascular disease. The widespread use of these therapies along with the rising cardiovascular disease accounts for the increasing market for cardiovascular therapeutics.

Cardiovascular therapeutic drugs refer to prescription medicines and drugs for diseases that are relating to the function and structure of the heart and blood vessels. Cardiovascular disease continues to be the major disease-causing health problem and responsible for the majority of deaths worldwide. Major drug administered areas for cardiovascular problems includes heart failure, coronary artery diseases, blood clots, high cholesterol, and others.

Cardiovascular disorders remain the most common cause of mortality and morbidity in the world and are an emerging threat. The primary drivers for the market include increasing aging population, growth in the per capita medical spending and the epidemic of general medical problems such as diabetes and obesity. 

However, increasing the cost of drug development and shrinking the target population are restraining the growth of the market. Despite the extensive prevalence of cardiovascular diseases, drug development pipelines have been stagnant for a variety of reasons.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Type, Production Technologies, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Bayer HealthCare AG, Bioniche Animal Halth Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health, Inc., Merck & Co. Inc. and Protein Sciences

 

This research report on the Global Cardiovascular Therapeutic Drugs Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.

Cardiovascular Therapeutic Drugs Market Analysis - By Disease Type:

  • Arteriosclerosis
  • Cardiac Arrhythmias
  • Myocardial Infarction
  • Acute Coronary Syndrome
  • Peripheral Artery Disease
  • Coronary Artery Disease
  • Hypertension
  • Hyperlipidaemia
  • Thrombosis
  • Cardiac Failure Diseases
  • Other Cardiovascular Diseases

Cardiovascular Therapeutic Drugs Market Analysis - By Drug Class:

  • Monotherapies
  • combination drug classes

Cardiovascular Therapeutic Drugs Market Analysis - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Companies leading the Global Cardiovascular Therapeutic Drugs Market profiled in the report are:

  1. AstraZeneca
  2. Novartis
  3. Bristol-Myers Squibb (BMS)
  4. Pfizer
  5. Sanofi
  6. Merck
  7. Bayer
  8. Takeda
  9. Boehringer Ingelheim
  10. Johnson & Johnson

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Disease                  

                                5.1.1 Arteriosclerosis     

                                5.1.2 Cardiac arrhythmias            

                                5.1.3 Myocardial infarction         

                                5.1.4 Acute Coronary Syndrome

                                5.1.5 Peripheral artery disease  

                                5.1.6 Coronary artery disease    

                                5.1.7 Hypertension        

                                5.1.8 Hyperlipidaemia   

                                5.1.9 Thrombosis            

                                5.1.10 Cardiac failure diseases  

                                5.1.11 Others   

                5.2 By Drug Class                             

                                5.2.1 Monotherapies     

                                5.2.2 Combination Therapies     

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                                6.3.6 Australia  

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Mexico     

                                6.4.4 Argentina

                                6.4.5 Rest of Latin America         

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7. Pipeline Product Analysis                                        

                7.1 Overview                                    

                7.2 Pipeline Development Landscape                                     

                7.3 Molecular Targets in the Pipeline                                     

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                 

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.               

8. Strategic Analysis                                       

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9. Market Leaders' Analysis                                        

                9.1 AstraZeneca               

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Strategic Evaluation and Operations            

                                9.1.4 Financial analysis  

                                9.1.5 Legal issues            

                                9.1.6 Recent Developments       

                                9.1.7 SWOT analysis       

                                9.1.8 Analyst View          

                9.2 Novartis                       

                9.3 Bristol-Myers Squibb                              

                9.4 Pfizer                            

                9.5 Sanofi                           

                9.6 Merck                           

                9.7 Bayer                            

                9.8 Takeda                         

                9.9 Boehringer Ingelheim                            

                9.10 Johnson & Johnson                              

10. Competitive Landscape                                         

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11. Expert Opinions                                        

                11.1 Market Outlook                     

                11.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Cardiovascular Therapeutic Drugs Market By Region, From 2019-2024 (USD billion)                                                           
  2. Global Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                          
  3. Global Arteriosclerosis Market By Region, From 2019-2024 (USD billion)                                               
  4. Global Cardiac arrhythmias Market By Region, From 2019-2024 (USD billion)                                                      
  5. Global Myocardial infarction Market By Region, From 2019-2024 (USD billion)                                                   
  6. Global Acute Coronary Syndrome Market By Region, From 2019-2024 (USD billion)                                                          
  7. Global Peripheral artery disease Market By Region, From 2019-2024 (USD billion)                                                            
  8. Global Coronary artery disease Market By Region, From 2019-2024 (USD billion)                                                               
  9. Global Hypertension Market By Region, From 2019-2024 (USD billion)                                                   
  10. Global Hyperlipidaemia Market By Region, From 2019-2024 (USD billion)                                                             
  11. Global Thrombosis Market By Region, From 2019-2024 (USD billion)                                                       
  12. Global Cardiac failure diseases Market By Region, From 2019-2024 (USD billion)                                               
  13. Global Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                    
  14. Global Monotherapies Market By Region, From 2019-2024 (USD billion)                                               
  15. Global Combination Therapies Market By Region, From 2019-2024 (USD billion)                                                
  16. North America Cardiovascular Therapeutic Drugs Market By Region, From 2019-2024 (USD billion)                                                           
  17. North America Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                         
  18. North America Arteriosclerosis Market By Region, From 2019-2024 (USD billion)                                                               
  19. North America Cardiac arrhythmias Market By Region, From 2019-2024 (USD billion)                                                      
  20. North America Myocardial infarction Market By Region, From 2019-2024 (USD billion)                                                   
  21. North America Acute Coronary Syndrome Market By Region, From 2019-2024 (USD billion)                                                         
  22. North America Peripheral artery disease Market By Region, From 2019-2024 (USD billion)                                                            
  23. North America Coronary artery disease Market By Region, From 2019-2024 (USD billion)                                                              
  24. North America Hypertension Market By Region, From 2019-2024 (USD billion)                                                   
  25. North America Hyperlipidaemia Market By Region, From 2019-2024 (USD billion)                                                             
  26. North America Thrombosis Market By Region, From 2019-2024 (USD billion)                                                      
  27. North America Cardiac failure diseases Market By Region, From 2019-2024 (USD billion)                                               
  28. North America Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                    
  29. North America Monotherapies Market By Region, From 2019-2024 (USD billion)                                                               
  30. North America Combination Therapies Market By Region, From 2019-2024 (USD billion)                                               
  31. United States Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                            
  32. United States Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                      
  33. Canada Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                        
  34. Canada Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                  
  35. Europe Cardiovascular Therapeutic Drugs Market By Region, From 2019-2024 (USD billion)                                                          
  36. Europe Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                        
  37. Europe Arteriosclerosis Market By Region, From 2019-2024 (USD billion)                                                              
  38. Europe Cardiac arrhythmias Market By Region, From 2019-2024 (USD billion)                                                     
  39. Europe Myocardial infarction Market By Region, From 2019-2024 (USD billion)                                                  
  40. Europe Acute Coronary Syndrome Market By Region, From 2019-2024 (USD billion)                                                        
  41. Europe Peripheral artery disease Market By Region, From 2019-2024 (USD billion)                                                           
  42. Europe Coronary artery disease Market By Region, From 2019-2024 (USD billion)                                                             
  43. Europe Hypertension Market By Region, From 2019-2024 (USD billion)                                                  
  44. Europe Hyperlipidaemia Market By Region, From 2019-2024 (USD billion)                                                            
  45. Europe Thrombosis Market By Region, From 2019-2024 (USD billion)                                                     
  46. Europe Cardiac failure diseases Market By Region, From 2019-2024 (USD billion)                                                              
  47. Europe Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                   
  48. Europe Monotherapies Market By Region, From 2019-2024 (USD billion)                                                              
  49. Europe Combination Therapies Market By Region, From 2019-2024 (USD billion)                                                              
  50. U.K Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                               
  51. U.K Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                          
  52. Spain Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                            
  53. Spain Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                      
  54. Germany Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                    
  55. Germany Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                               
  56. Italy Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                              
  57. Italy Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                        
  58. France Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                         
  59. France Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                    
  60. Asia-Pacific Cardiovascular Therapeutic Drugs Market By Region, From 2019-2024 (USD billion)                                                 
  61. Asia-Pacific Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                
  62. Asia-Pacific Arteriosclerosis Market By Region, From 2019-2024 (USD billion)                                                     
  63. Asia-Pacific Cardiac arrhythmias Market By Region, From 2019-2024 (USD billion)                                                            
  64. Asia-Pacific Myocardial infarction Market By Region, From 2019-2024 (USD billion)                                                          
  65. Asia-Pacific Acute Coronary Syndrome Market By Region, From 2019-2024 (USD billion)                                                
  66. Asia-Pacific Peripheral artery disease Market By Region, From 2019-2024 (USD billion)                                                   
  67. Asia-Pacific Coronary artery disease Market By Region, From 2019-2024 (USD billion)                                                     
  68. Asia-Pacific Hypertension Market By Region, From 2019-2024 (USD billion)                                                         
  69. Asia-Pacific Hyperlipidaemia Market By Region, From 2019-2024 (USD billion)                                                    
  70. Asia-Pacific Thrombosis Market By Region, From 2019-2024 (USD billion)                                                             
  71. Asia-Pacific Cardiac failure diseases Market By Region, From 2019-2024 (USD billion)                                                      
  72. Asia-Pacific Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                           
  73. Asia-Pacific Monotherapies Market By Region, From 2019-2024 (USD billion)                                                      
  74. Asia-Pacific Combination Therapies Market By Region, From 2019-2024 (USD billion)                                                      
  75. China Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                           
  76. China Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                      
  77. India Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                             
  78. India Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                       
  79. Japan Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                           
  80. Japan Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                      
  81. South Korea Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                              
  82. South Korea Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                         
  83. Australia Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                     
  84. Australia Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                               
  85. Latin America Cardiovascular Therapeutic Drugs Market By Region, From 2019-2024 (USD billion)                                                             
  86. Latin America Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                           
  87. Latin America Arteriosclerosis Market By Region, From 2019-2024 (USD billion)                                                 
  88. Latin America Cardiac arrhythmias Market By Region, From 2019-2024 (USD billion)                                                       
  89. Latin America Myocardial infarction Market By Region, From 2019-2024 (USD billion)                                                     
  90. Latin America Acute Coronary Syndrome Market By Region, From 2019-2024 (USD billion)                                                           
  91. Latin America Peripheral artery disease Market By Region, From 2019-2024 (USD billion)                                                              
  92. Latin America Coronary artery disease Market By Region, From 2019-2024 (USD billion)                                                
  93. Latin America Hypertension Market By Region, From 2019-2024 (USD billion)                                                     
  94. Latin America Hyperlipidaemia Market By Region, From 2019-2024 (USD billion)                                                               
  95. Latin America Thrombosis Market By Region, From 2019-2024 (USD billion)                                                        
  96. Latin America Cardiac failure diseases Market By Region, From 2019-2024 (USD billion)                                                 
  97. Latin America Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                      
  98. Latin America Monotherapies Market By Region, From 2019-2024 (USD billion)                                                 
  99. Latin America Combination Therapies Market By Region, From 2019-2024 (USD billion)                                                 
  100. Brazil Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                           
  101. Brazil Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                      
  102. Argentina Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                   
  103. Argentina Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                             
  104. Mexico Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                        
  105. Mexico Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                  
  106. Middle East & Africa Cardiovascular Therapeutic Drugs Market By Region, From 2019-2024 (USD billion)                                               
  107. Middle East & Africa Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                              
  108. Middle East & Africa Arteriosclerosis Market By Region, From 2019-2024 (USD billion)                                                   
  109. Middle East & Africa Cardiac arrhythmias Market By Region, From 2019-2024 (USD billion)                                                          
  110. Middle East & Africa Myocardial infarction Market By Region, From 2019-2024 (USD billion)                                                        
  111. Middle East & Africa Acute Coronary Syndrome Market By Region, From 2019-2024 (USD billion)                                                              
  112. Middle East & Africa Peripheral artery disease Market By Region, From 2019-2024 (USD billion)                                                 
  113. Middle East & Africa Coronary artery disease Market By Region, From 2019-2024 (USD billion)                                                   
  114. Middle East & Africa Hypertension Market By Region, From 2019-2024 (USD billion)                                                       
  115. Middle East & Africa Hyperlipidaemia Market By Region, From 2019-2024 (USD billion)                                                 
  116. Middle East & Africa Thrombosis Market By Region, From 2019-2024 (USD billion)                                                           
  117. Middle East & Africa Cardiac failure diseases Market By Region, From 2019-2024 (USD billion)                                                    
  118. Middle East & Africa Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                        
  119. Middle East & Africa Monotherapies Market By Region, From 2019-2024 (USD billion)                                                   
  120. Middle East & Africa Combination Therapies Market By Region, From 2019-2024 (USD billion)                                                    
  121. Middle East Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                               
  122. Middle East Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                          
  123. Africa Cardiovascular Therapeutic Drugs Market By Disease, From 2019-2024 (USD billion)                                                           
  124. Africa Cardiovascular Therapeutic Drugs Market By Drug Class, From 2019-2024 (USD billion)                                                     

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample